MEDIGENE N

BE:MDG1 Germany Other
Market Cap
$6.26K
€6.10K EUR
Market Cap Rank
#45644 Global
#7563 in Germany
Share Price
€0.65
Change (1 day)
+0.00%
52-Week Range
€0.62 - €1.56
All Time High
€35.39
About

MEDIGENE N operates in Diversified Metals & Mining.

MEDIGENE N (MDG1) - Total Liabilities

Latest total liabilities as of June 2024: €9.15 Million EUR

Based on the latest financial reports, MEDIGENE N (MDG1) has total liabilities worth €9.15 Million EUR as of June 2024.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

MEDIGENE N - Total Liabilities Trend (2016–2023)

This chart illustrates how MEDIGENE N's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

MEDIGENE N Competitors by Total Liabilities

The table below lists competitors of MEDIGENE N ranked by their total liabilities.

Company Country Total Liabilities
Alternate Health Corp
PINK:AHGIF
USA $30.66 Million
Amcomri Entertainment Inc
PINK:AMNNF
USA $3.27 Million
Vodka Brands Corp
PINK:VDKB
USA $182.66K
Tap Resources Inc
PINK:TAPP
USA $184.14K

Liability Composition Analysis (2016–2023)

This chart breaks down MEDIGENE N's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.39 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.47 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.32 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how MEDIGENE N's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for MEDIGENE N (2016–2023)

The table below shows the annual total liabilities of MEDIGENE N from 2016 to 2023.

Year Total Liabilities Change
2023-12-31 €10.65 Million -27.32%
2022-12-31 €14.65 Million -0.02%
2021-12-31 €14.65 Million -32.15%
2020-12-31 €21.60 Million -21.16%
2019-12-31 €27.39 Million +23.58%
2018-12-31 €22.16 Million -13.99%
2017-12-31 €25.77 Million -22.20%
2016-12-31 €33.12 Million --